BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
BusinessNew U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum ProductsBy Nasdaq OMXNov 16, 2016, 2:01 PM UTC
BusinessHemispherx Biopharma Announces Financial Results in its Quarterly Report for the Nine Months Ended September 30, 2016By Nasdaq OMXNov 14, 2016, 9:36 PM UTC
BusinessHemispherx Biopharma Announces Conference Call to Provide Quarterly Business Update on November 15, 2016By Nasdaq OMXNov 10, 2016, 1:31 PM UTC
BusinessHemispherx Biopharma Announces Conference Call to Provide Quarterly Business Update on November 15, 2016By Nasdaq OMXNov 10, 2016, 1:31 PM UTC
BusinessHemispherx Biopharma Featured in Corporate America News Magazine Special Report “Capturing the Power of Immune Response to Treat Disease: Biotech Bounce Back”By Nasdaq OMXNov 8, 2016, 1:30 PM UTC
BusinessHemispherx Biopharma Announces Completion of Ampligen® Manufacturing Technology Transfer MilestoneBy Nasdaq OMXOct 19, 2016, 12:30 PM UTC
BusinessNeoTract selects TikaDevice™ as an End-to-End Mobile CRM Solution for its UroLift® SystemBy Nasdaq OMXOct 14, 2016, 5:12 PM UTC
